Build Your Comparison

Side-by-side financial analysis
FLGC logo
FLGC
SNDL logo
SNDL
CRON logo
CRON
TLRY logo
TLRY
CGC logo
CGC
JPM logo
JPM
Try popular comparisons:

Stock Comparison

FLGC vs SNDL vs CRON vs TLRY vs CGC vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FLGC
Flora Growth Corp.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$88M
5Y Perf.-99.8%
SNDL
SNDL Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$368M
5Y Perf.-84.1%
CRON
Cronos Group Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$1.01B
5Y Perf.-70.4%
TLRY
Tilray Brands, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$551M
5Y Perf.-52.8%
CGC
Canopy Growth Corporation

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$372M
5Y Perf.-99.6%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+82.8%

FLGC vs SNDL vs CRON vs TLRY vs CGC vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FLGC logoFLGC
SNDL logoSNDL
CRON logoCRON
TLRY logoTLRY
CGC logoCGC
JPM logoJPM
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericBanks - Diversified
Market Cap$88M$368M$1.01B$551M$372M$908.57B
Revenue (TTM)$14M$937M$206M$1.17B$312M$280.33B
Net Income (TTM)$-120M$-11M$-2M$-2.95B$-367M$57.05B
Gross Margin43.3%27.2%32.8%28.0%24.9%60.0%
Operating Margin-30.7%-0.8%-0.1%-266.0%-33.0%25.9%
Forward P/E31.0x14.6x
Total Debt$54M$170M$2M$451M$325M$942.38B
Cash & Equiv.$6M$273M$792M$304M$509M$343.34B

FLGC vs SNDL vs CRON vs TLRY vs CGC vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FLGC
SNDL
CRON
TLRY
CGC
JPM
StockMay 21Mar 26Return
Flora Growth Corp. (FLGC)1000.2-99.8%
SNDL Inc. (SNDL)10015.9-84.1%
Cronos Group Inc. (CRON)10029.6-70.4%
Tilray Brands, Inc. (TLRY)10047.2-52.8%
Canopy Growth Corpo… (CGC)1000.4-99.6%
JPMorgan Chase & Co. (JPM)100182.8+82.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: FLGC vs SNDL vs CRON vs TLRY vs CGC vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM leads in 5 of 7 categories (6-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Tilray Brands, Inc. is the stronger pick specifically for recent price momentum and sentiment. CGC also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
FLGC
Flora Growth Corp.
The Healthcare Pick

FLGC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
SNDL
SNDL Inc.
The Healthcare Pick

Among these 6 stocks, SNDL doesn't own a clear edge in any measured category.

Best for: healthcare exposure
CRON
Cronos Group Inc.
The Long-Run Compounder

CRON is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 15.4% 10Y total return vs JPM's 481.2%
  • Lower volatility, beta 0.93, Low D/E 0.1%, current ratio 19.59x
  • Beta 0.93, current ratio 19.59x
Best for: long-term compounding and sleep-well-at-night
TLRY
Tilray Brands, Inc.
The Momentum Pick

TLRY is the #2 pick in this set and the best alternative if momentum is your priority.

  • +11.3% vs FLGC's -74.3%
Best for: momentum
CGC
Canopy Growth Corporation
The Growth Play

CGC ranks third and is worth considering specifically for growth exposure.

  • Rev growth 79.8%, EPS growth 84.1%, 3Y rev CAGR 13.2%
  • 79.8% revenue growth vs FLGC's -75.6%
Best for: growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM carries the broadest edge in this set and is the clearest fit for income & stability.

  • Dividend streak 15 yrs, beta 0.87, yield 1.8%
  • Better valuation composite
  • 20.4% margin vs FLGC's -8.3%
  • Beta 0.87 vs FLGC's 3.12
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthCGC logoCGC79.8% revenue growth vs FLGC's -75.6%
ValueJPM logoJPMBetter valuation composite
Quality / MarginsJPM logoJPM20.4% margin vs FLGC's -8.3%
Stability / SafetyJPM logoJPMBeta 0.87 vs FLGC's 3.12
DividendsJPM logoJPM1.8% yield; 15-year raise streak; the other 5 pay no meaningful dividend
Momentum (1Y)TLRY logoTLRY+11.3% vs FLGC's -74.3%
Efficiency (ROA)JPM logoJPM1.3% ROA vs FLGC's -192.1%, ROIC 4.5% vs -5.5%

FLGC vs SNDL vs CRON vs TLRY vs CGC vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FLGCFlora Growth Corp.
FY 2021
Pharmaceuticals and Nutraceuticals
100.0%$2M
SNDLSNDL Inc.
FY 2022
Cannabis
100.0%$62M
CRONCronos Group Inc.
FY 2025
Cannabis Flower
74.0%$108M
Cannabis Extracts
25.7%$38M
Product and Service, Other
0.3%$411,000
TLRYTilray Brands, Inc.
FY 2025
Cannabis Segment
36.1%$331M
Distribution Revenue
29.6%$271M
Beverage Alcohol Business
27.7%$253M
Wellness Business
6.6%$60M
CGCCanopy Growth Corporation
FY 2025
Other Revenue
0.0%$0
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

FLGC vs SNDL vs CRON vs TLRY vs CGC vs JPM — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGCGC

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 4 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 19334.6x FLGC's $14M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to FLGC's -8.3%. On growth, CRON holds the edge at +38.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFLGC logoFLGCFlora Growth Corp.SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.TLRY logoTLRYTilray Brands, In…CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$14M$937M$206M$1.2B$312M$280.3B
EBITDAEarnings before interest/tax-$4M$49M$3M-$3.0B-$63M$81.4B
Net IncomeAfter-tax profit-$120M-$11M-$2M-$2.9B-$367M$57.0B
Free Cash FlowCash after capex-$9M$53M$26M-$94M-$77M$100.9B
Gross MarginGross profit ÷ Revenue+43.3%+27.2%+32.8%+28.0%+24.9%+60.0%
Operating MarginEBIT ÷ Revenue-30.7%-0.8%-0.1%-2.7%-33.0%+25.9%
Net MarginNet income ÷ Revenue-8.3%-1.2%-1.0%-2.5%-117.4%+20.4%
FCF MarginFCF ÷ Revenue-63.5%+5.6%+12.9%-8.1%-24.6%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year-2.6%-4.4%+38.2%+3.0%+9.6%
EPS Growth (YoY)Latest quarter vs prior year+2.6%+32.8%+124.7%+70.7%+72.0%+16.0%
JPM leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SNDL and TLRY each lead in 2 of 6 comparable metrics.

On an enterprise value basis, SNDL's 8.0x EV/EBITDA is more attractive than JPM's 18.5x.

MetricFLGC logoFLGCFlora Growth Corp.SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.TLRY logoTLRYTilray Brands, In…CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …
Market CapShares × price$88M$368M$1.0B$551M$372M$908.6B
Enterprise ValueMkt cap + debt − cash$87M$295M$222M$698M$243M$1.51T
Trailing P/EPrice ÷ TTM EPS-5.55x-33.38x-110.61x-0.14x-1.55x16.22x
Forward P/EPrice ÷ next-FY EPS est.30.97x14.60x
PEG RatioP/E ÷ EPS growth rate0.92x
EV / EBITDAEnterprise value multiple8.04x18.52x
Price / SalesMarket cap ÷ Revenue1.49x0.55x5.24x0.49x1.09x3.25x
Price / BookPrice ÷ Book value/share19.61x0.47x0.91x0.21x4.18x2.51x
Price / FCFMarket cap ÷ FCF8.93x6679.09x9.01x
Evenly matched — SNDL and TLRY each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

JPM leads this category, winning 5 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-3 for FLGC. CRON carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CRON scores 7/9 vs FLGC's 3/9, reflecting strong financial health.

MetricFLGC logoFLGCFlora Growth Corp.SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.TLRY logoTLRYTilray Brands, In…CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-3.3%-1.0%-0.2%-136.5%-49.5%+15.9%
ROA (TTM)Return on assets-192.1%-0.8%-0.2%-100.6%-31.8%+1.3%
ROICReturn on invested capital-5.5%-0.3%-0.7%-66.2%-16.0%+4.5%
ROCEReturn on capital employed-6.9%-0.4%-0.3%-78.1%-15.0%+8.9%
Piotroski ScoreFundamental quality 0–9367455
Debt / EquityFinancial leverage0.76x0.15x0.00x0.22x0.33x2.60x
Net DebtTotal debt minus cash$48M-$102M-$790M$147M-$183M$599.0B
Cash & Equiv.Liquid assets$6M$273M$792M$304M$509M$343.3B
Total DebtShort + long-term debt$54M$170M$2M$451M$325M$942.4B
Interest CoverageEBIT ÷ Interest expense-18.87x-1.16x-89.43x-5.99x0.74x
JPM leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TLRY leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $25 for FLGC. Over the past 12 months, TLRY leads with a +1134.0% total return vs FLGC's -74.3%. The 3-year compound annual growth rate (CAGR) favors TLRY at 45.0% vs FLGC's -62.9% — a key indicator of consistent wealth creation.

MetricFLGC logoFLGCFlora Growth Corp.SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.TLRY logoTLRYTilray Brands, In…CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+5.3%-18.4%+0.4%-51.3%-18.7%+0.8%
1-Year ReturnPast 12 months-74.3%+11.8%+41.9%+1134.0%-25.0%+20.9%
3-Year ReturnCumulative with dividends-94.9%+2.9%+58.5%+205.2%-84.0%+138.8%
5-Year ReturnCumulative with dividends-99.8%-84.6%-67.5%-72.0%-99.6%+135.5%
10-Year ReturnCumulative with dividends-99.8%-98.3%+1542.4%-78.9%-95.4%+481.2%
CAGR (3Y)Annualised 3-year return-62.9%+1.0%+16.6%+45.0%-45.7%+33.7%
TLRY leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

JPM leads this category, winning 2 of 2 comparable metrics.

JPM is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than FLGC's 3.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs FLGC's 15.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFLGC logoFLGCFlora Growth Corp.SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.TLRY logoTLRYTilray Brands, In…CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5003.12x1.10x0.93x1.93x1.74x0.87x
52-Week HighHighest price in past year$47.00$2.89$3.43$15.70$2.38$338.09
52-Week LowLowest price in past year$5.86$1.15$1.84$0.35$0.84$269.72
% of 52W HighCurrent price vs 52-week peak+15.3%+49.1%+79.0%+30.1%+40.6%+96.2%
RSI (14)Momentum oscillator 0–10047.149.947.133.833.272.1
Avg Volume (50D)Average daily shares traded11K2.3M1.6M4.9M10.1M7.4M
JPM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

JPM leads this category, winning 1 of 1 comparable metric.

Analyst consensus: SNDL as "Hold", CRON as "Hold", TLRY as "Hold", CGC as "Hold", JPM as "Buy". Consensus price targets imply 1396.1% upside for CGC (target: $14) vs -15.1% for CRON (target: $2). JPM is the only dividend payer here at 1.83% yield — a key consideration for income-focused portfolios.

MetricFLGC logoFLGCFlora Growth Corp.SNDL logoSNDLSNDL Inc.CRON logoCRONCronos Group Inc.TLRY logoTLRYTilray Brands, In…CGC logoCGCCanopy Growth Cor…JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellHoldHoldHoldHoldBuy
Price TargetConsensus 12-month target$3.95$2.30$10.00$14.47$339.75
# AnalystsCovering analysts615202661
Dividend YieldAnnual dividend ÷ price+1.8%
Dividend StreakConsecutive years of raises015
Dividend / ShareAnnual DPS$5.95
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.0%+1.0%0.0%0.0%+3.8%
JPM leads this category, winning 1 of 1 comparable metric.
Key Takeaway

JPM leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TLRY leads in 1 (Total Returns). 1 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 4 of 6 categories
Loading custom metrics...

FLGC vs SNDL vs CRON vs TLRY vs CGC vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FLGC or SNDL or CRON or TLRY or CGC or JPM a better buy right now?

For growth investors, Canopy Growth Corporation (CGC) is the stronger pick with 79.

8% revenue growth year-over-year, versus -75. 6% for Flora Growth Corp. (FLGC). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FLGC or SNDL or CRON or TLRY or CGC or JPM?

On forward P/E, JPMorgan Chase & Co.

is actually cheaper at 14. 6x.

03

Which is the better long-term investment — FLGC or SNDL or CRON or TLRY or CGC or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -99. 8% for Flora Growth Corp. (FLGC). Over 10 years, the gap is even starker: CRON returned +1542% versus FLGC's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FLGC or SNDL or CRON or TLRY or CGC or JPM?

By beta (market sensitivity over 5 years), JPMorgan Chase & Co.

(JPM) is the lower-risk stock at 0. 87β versus Flora Growth Corp. 's 3. 12β — meaning FLGC is approximately 259% more volatile than JPM relative to the S&P 500. On balance sheet safety, Cronos Group Inc. (CRON) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FLGC or SNDL or CRON or TLRY or CGC or JPM?

By revenue growth (latest reported year), Canopy Growth Corporation (CGC) is pulling ahead at 79.

8% versus -75. 6% for Flora Growth Corp. (FLGC). On earnings-per-share growth, the picture is similar: Flora Growth Corp. grew EPS 100. 0% year-over-year, compared to -651. 7% for Tilray Brands, Inc.. Over a 3-year CAGR, CRON leads at 30. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FLGC or SNDL or CRON or TLRY or CGC or JPM?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -266. 3% for Tilray Brands, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -277. 9% for TLRY. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FLGC or SNDL or CRON or TLRY or CGC or JPM more undervalued right now?

On forward earnings alone, JPMorgan Chase & Co.

(JPM) trades at 14. 6x forward P/E versus 31. 0x for Cronos Group Inc. — 16. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CGC: 1396. 1% to $14. 47.

08

Which pays a better dividend — FLGC or SNDL or CRON or TLRY or CGC or JPM?

In this comparison, JPM (1.

8% yield) pays a dividend. FLGC, SNDL, CRON, TLRY, CGC do not pay a meaningful dividend and should not be held primarily for income.

09

Is FLGC or SNDL or CRON or TLRY or CGC or JPM better for a retirement portfolio?

For long-horizon retirement investors, Cronos Group Inc.

(CRON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), +1542% 10Y return). Flora Growth Corp. (FLGC) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRON: +1542%, FLGC: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FLGC and SNDL and CRON and TLRY and CGC and JPM?

These companies operate in different sectors (FLGC (Healthcare) and SNDL (Healthcare) and CRON (Healthcare) and TLRY (Healthcare) and CGC (Healthcare) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FLGC is a small-cap quality compounder stock; SNDL is a small-cap quality compounder stock; CRON is a small-cap high-growth stock; TLRY is a small-cap quality compounder stock; CGC is a small-cap high-growth stock; JPM is a large-cap deep-value stock. JPM pays a dividend while FLGC, SNDL, CRON, TLRY, CGC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.